Detalhe da pesquisa
1.
Exposure-response relationship of cabozantinib in patients with metastatic renal cell carcinoma treated in routine care.
Br J Cancer
; 130(6): 961-969, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38272963
2.
Efficacy of Selpercatinib in RET-Altered Thyroid Cancers.
N Engl J Med
; 383(9): 825-835, 2020 08 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-32846061
3.
A phase II study of Navitoclax (ABT-263) as single agent in women heavily pretreated for recurrent epithelial ovarian cancer: The MONAVI - GINECO study.
Gynecol Oncol
; 165(1): 30-39, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35123771
4.
The fully synthetic glycopeptide MAG-Tn3 therapeutic vaccine induces tumor-specific cytotoxic antibodies in breast cancer patients.
Cancer Immunol Immunother
; 69(5): 703-716, 2020 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-32034426
5.
[Hereditary breast and ovarian cancer syndrome: Diagnosis and therapeutic implications]. / Syndrome héréditaire de prédisposition au cancer du sein et de l'ovaire : diagnostic et implications thérapeutiques.
Ann Pathol
; 40(2): 70-77, 2020 Apr.
Artigo
em Francês
| MEDLINE | ID: mdl-32046878
6.
Efficacy and safety of Vinflunine for advanced or metastatic urothelial carcinoma in routine practice based on the French multi-centre CURVE study.
BMC Cancer
; 16: 217, 2016 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-26975779
7.
Olaparib Addition to Maintenance Bevacizumab Therapy in Ovarian Carcinoma With BRCA-Like Genomic Aberrations.
JAMA Netw Open
; 7(4): e245552, 2024 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38592722
8.
Rechallenge with mTOR inhibitors in metastatic renal cell carcinoma patients who progressed on previous mTOR inhibitor therapy.
Oncology
; 85(1): 8-13, 2013.
Artigo
em Inglês
| MEDLINE | ID: mdl-23797151
9.
Ovarian cancer: sites of recurrence.
Int J Gynecol Cancer
; 23(9): 1590-6, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24172095
10.
Benefits of Homeopathic Complementary Treatment in Patients With Breast Cancer: A Retrospective Cohort Study Based on the French Nationwide Healthcare Database.
Clin Breast Cancer
; 23(1): 60-70, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36376237
11.
Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations: Solid organ recipients and cancer patients.
Therapie
; 78(3): 267-278, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-35729008
12.
Retrospective analysis of real-world data to evaluate actionability of a comprehensive molecular profiling panel in solid tumor tissue samples (REALM study).
PLoS One
; 18(9): e0291495, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37708140
13.
Long-term response and postsurgical complete remissions after treatment with sunitinib malate, an oral multitargeted receptor tyrosine kinase inhibitor, in patients with metastatic renal cell carcinoma.
Cancer Invest
; 29(4): 282-5, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21469976
14.
Association between Olaparib Exposure and Early Toxicity in BRCA-Mutated Ovarian Cancer Patients: Results from a Retrospective Multicenter Study.
Pharmaceuticals (Basel)
; 14(8)2021 Aug 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-34451901
15.
Metastatic renal carcinoma: evaluation of antiangiogenic therapy with dynamic contrast-enhanced CT.
Radiology
; 256(2): 511-8, 2010 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-20551183
16.
First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity.
J Transl Med
; 8: 71, 2010 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-20653948
17.
A universal formula based on cystatin C to perform individual dosing of carboplatin in normal weight, underweight, and obese patients.
Clin Cancer Res
; 15(10): 3633-9, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19401344
18.
A First-in-Human Phase I Study of INVAC-1, an Optimized Human Telomerase DNA Vaccine in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 26(3): 588-597, 2020 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31558479
19.
Response of renal cell carcinoma pancreatic metastasis to sunitinib treatment: a retrospective analysis.
J Urol
; 181(6): 2470-5; discussion 2475, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19371877
20.
What is the real impact of bone pain on survival in patients with metastatic hormone-refractory prostate cancer treated with docetaxel?
BJU Int
; 103(12): 1641-6, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19210673